Government and Regulations

FDA announces new potential side effects for varenicline


 

References

The Food and Drug Administration is warning physicians and patients that taking varenicline for smoking cessation can change a patient’s reaction to alcohol and can cause seizures* in patients without prior history.

Some patients who have drunk alcohol while taking varenicline, marketed as Chantix, have reported decreased tolerance to alcohol, including symptoms such as increased drunkenness, unusual or aggressive behavior, or memory loss. Patients have also reported incidence of seizure within a month of starting varenicline, despite having no previous history of seizure.

“Until patients know how Chantix affects their ability to tolerate alcohol, they should decrease the amount of alcohol they drink. Patients who have a seizure while taking Chantix should stop the medicine and seek medical attention immediately,” the FDA recommended.

Find the full announcement on the FDA website.

*Correction, 3/11/2015: An earlier version of this article misstated one of the side effects of varenicline.

Recommended Reading

Health care association transmission major factor in MERS-CoV outbreak
MDedge Family Medicine
The 2014 AAP COID update on palivizumab
MDedge Family Medicine
Selling the better mousetrap
MDedge Family Medicine
Are inhaled steroids effective for a postviral cough?
MDedge Family Medicine
Early pneumonia linked with later asthma and wheeze
MDedge Family Medicine
ACIP votes to drop preference for LAIV in healthy children aged 2-8 years
MDedge Family Medicine
Environmental factors could increase U.S. anthrax cases
MDedge Family Medicine
FDA panel recommends two new strains for 2015-2016 influenza vaccines
MDedge Family Medicine
Studies of anesthesia’s effect on upper airway are limited
MDedge Family Medicine
Microbiome and innate immunity in the respiratory tract – a primer
MDedge Family Medicine